Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuela Merli

Showing results (181-190 of 216) with videos related to

Pageof 22
Sort By:
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational studySalvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Minerva Gastroenterologica E Dietologica|January 9, 2018
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohortAlfredo Marzano, Pietro Andreone, Patrizia Boccagni, et al.
Canadian Liver Journal|August 22, 2022
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplantVictor Dong, Maxime Gosselin, Nishita Jagarlamudi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic ScoresDario Saltini, Silvia Nardelli, Roberto Miraglia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 16, 2024
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosisSebastián Marciano, Salvatore Piano, Virendra Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2019
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter StudyMichele Bartoletti, Maddalena Giannella, Russell E Lewis, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosisDavide Roccarina, Dario Saltini, Valentina Adotti, et al.
Frontiers in Medicine|June 12, 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter studyOliviero Riggio, Ciro Celsa, Vincenza Calvaruso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2026
Prevention of Portal Hypertension Complications Beyond Primary TIPS Indication Is Independent of Endoprosthesis Under-DilationDavide Roccarina, Dario Saltini, Marco Senzolo, et al.
JHEP Reports : Innovation in Hepatology|January 8, 2026
Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPSDavide Roccarina, Dario Saltini, Marco Senzolo, et al.
Pageof 22

Showing results (181-190 of 216) with videos related to

Sort By:
Pageof 22
The Lancet. Gastroenterology & Hepatology|May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational studySalvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Minerva Gastroenterologica E Dietologica|January 9, 2018
Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohortAlfredo Marzano, Pietro Andreone, Patrizia Boccagni, et al.
Canadian Liver Journal|August 22, 2022
Proceedings from the 2018 Canadian Association for the Study of the Liver Single Topic Conference-Decompensated cirrhosis: from clinic to transplantVictor Dong, Maxime Gosselin, Nishita Jagarlamudi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 8, 2026
Sarcopenia Predicts Mortality and Hepatic Encephalopathy After TIPS in Older Adults With Cirrhosis and Improves Prognostic ScoresDario Saltini, Silvia Nardelli, Roberto Miraglia, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 16, 2024
Development and external validation of a model to predict multidrug-resistant bacterial infections in patients with cirrhosisSebastián Marciano, Salvatore Piano, Virendra Singh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2019
Extended Infusion of β-Lactams for Bloodstream Infection in Patients With Liver Cirrhosis: An Observational Multicenter StudyMichele Bartoletti, Maddalena Giannella, Russell E Lewis, et al.
Hepatology (Baltimore, Md.)|January 8, 2025
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective TIPS in patients with cirrhosisDavide Roccarina, Dario Saltini, Valentina Adotti, et al.
Frontiers in Medicine|June 12, 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter studyOliviero Riggio, Ciro Celsa, Vincenza Calvaruso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 27, 2026
Prevention of Portal Hypertension Complications Beyond Primary TIPS Indication Is Independent of Endoprosthesis Under-DilationDavide Roccarina, Dario Saltini, Marco Senzolo, et al.
JHEP Reports : Innovation in Hepatology|January 8, 2026
Shunt magnitude is a key determinant of overt hepatic encephalopathy in patients undergoing TIPSDavide Roccarina, Dario Saltini, Marco Senzolo, et al.
Pageof 22